Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains

被引:28
作者
Adnan, Syamhanin [1 ,2 ,3 ]
Li, Janice Xuanhui [4 ]
Wallis, Steven C. [1 ]
Rudd, Michael [1 ,5 ]
Jarrett, Paul [1 ]
Paterson, David L. [2 ,3 ,6 ]
Lipman, Jeffrey [1 ,7 ]
Udy, Andrew A. [1 ,7 ]
Roberts, Jason A. [1 ,7 ,8 ]
机构
[1] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[2] Univ Queensland, Brisbane, Qld, Australia
[3] Univ Queensland, Ctr Clin Res, Brisbane, Qld, Australia
[4] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Dept Surg, Brisbane, Qld 4029, Australia
[6] Royal Brisbane & Womens Hosp, Dept Infect Dis, Brisbane, Qld 4029, Australia
[7] Royal Brisbane & Womens Hosp, Dept Intens Care Med, Brisbane, Qld 4029, Australia
[8] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld 4029, Australia
基金
英国医学研究理事会;
关键词
Pharmacokinetic; Meropenem; Piperacillin; Critically ill; Surgical drain; SEPTIC SHOCK; PENETRATION;
D O I
10.1016/j.ijantimicag.2013.02.023
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Meropenem and piperacillin are two commonly prescribed antibiotics in critically ill surgical patients. To date, the pharmacokinetics of these antibiotics in the presence of indwelling abdominal surgical drains is poorly defined. This was a prospective pharmacokinetic study of meropenem and piperacillin. Serial plasma, urine and surgical drain fluid samples were collected over one dosing interval of antibiotic treatment in ten patients (meropenem, n = 5; piperacillin n = 5). Drug concentrations were measured using a validated high-performance liquid chromatography assay. Median (interquartile range) pharmacokinetic parameter estimates for meropenem were as follows: area under concentration-time curve (AUC), 128.7 mg h/L (95.3-176.7 mg h/L); clearance (CL), 5.7 L/h (5.1-10.5 L/h); volume of distribution (Vd), 0.41 L/kg (0.35-0.56 L/kg); AUC ratio (drain: plasma), 0.2 (0.1-0.2); and calculated antibiotic clearance via surgical drain, 3.8% (2.8-5.4%). For piperacillin, unbound pharmacokinetic results were as follows; AUC, 344.3 mg h/L (341.1-348.4 mg h/L); CL, 13.1 L/h (12.9-13.2 L/h); Vd, 0.63 L/kg (0.38-1.28 L/kg); AUC ratio (drain: plasma), 0.2 (0.2-0.3); and calculated antibiotic clearance via surgical drain 8.2% (3.3-14.0%). A linear correlation was present between the percentage of antibiotic cleared through the drain and the volume of surgical drain fluid output for meropenem (r(2) = 0.89; P = 0.05) and piperacillin (r(2) = 0.63; P = 0.20). Meropenem and piperacillin have altered pharmacokinetics in critically ill patients with indwelling surgical drains. We propose that only when very high drain fluid output is present (>1000 mL/day) would an additional dose of antibiotic be necessary. (C) 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:90 / 93
页数:4
相关论文
共 15 条
[1]   Pharmacokinetics of Beta-Lactam Antibiotics in Patients with Intra-Abdominal Disease: A Structured Review [J].
Adnan, Syamhanin ;
Paterson, David L. ;
Lipman, Jeffrey ;
Kumar, Suresh ;
Li, Janice ;
Rudd, Michael ;
Roberts, Jason A. .
SURGICAL INFECTIONS, 2012, 13 (01) :9-17
[2]   PHARMACOKINETICS OF MEROPENEM IN PATIENTS WITH INTRAABDOMINAL INFECTIONS [J].
BEDIKIAN, A ;
OKAMOTO, MP ;
NAKAHIRO, RK ;
FARINO, J ;
HESELTINE, PNR ;
APPLEMAN, MD ;
YELLIN, AE ;
BERNE, TV ;
GILL, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (01) :151-154
[3]   Penetration of meropenem in plasma and abdominal tissues from patients undergoing intraabdominal surgery [J].
Condon, RE ;
Walker, AP ;
Hanna, CB ;
Greenberg, RN ;
Broom, A ;
Pitkin, D .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S181-S183
[4]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[5]  
European Committee on Antimicrobial Susceptibility Testing, 2011, CAL ZON DIAM BREAKP
[6]   Impaired target site penetration of β-lactams may account for therapeutic failure in patients with septic shock [J].
Joukhadar, C ;
Frossard, M ;
Mayer, BX ;
Brunner, M ;
Klein, N ;
Siostrzonek, P ;
Eichler, HG ;
Müller, M .
CRITICAL CARE MEDICINE, 2001, 29 (02) :385-391
[7]   Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock [J].
Karjagin, J. ;
Lefeuvre, S. ;
Oselin, K. ;
Kipper, K. ;
Marchand, S. ;
Tikkerberi, A. ;
Starkopf, J. ;
Couet, W. ;
Sawchuk, R. J. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (03) :452-459
[8]   Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection [J].
Li, CH ;
Kuti, JL ;
Nightingale, CH ;
Mansfield, DL ;
Dana, A ;
Nicolau, DP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (02) :388-395
[9]  
Ngo QD, 2004, DROWNING DRAINAGE LI
[10]   PHARMACOKINETICS OF MEROPENEM COMPARED TO IMIPENEM-CILASTATIN IN YOUNG, HEALTHY-MALES [J].
NILSSONEHLE, I ;
HUTCHISON, M ;
HAWORTH, SJ ;
NORRBY, SR .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (02) :85-88